foto

Prof. dr. M.I. van Berge Henegouwen MD PhD

Position
Professor
Main activities
Patient care, Research
Specialisation
gastrointestinal surgery - esophageal and gastric surgery
Focus of research

 Esophageal and gastric surgery is major GI surgery with high morbidity and a high postoperative recurrence rate of disease.

The research line focuses on direct postoperative care and improvenment through 1. new minimally invasive techniques, 2. better pre and postoperative care (rehabilitation), 3. evaluation of Quality of Life. Furthermore research gives insight in neo adjuvant techniques and evaluation of tumor response. 

Other focus is on improving outcome of esophageal and gastric cancer care on a national level through research with the Dutch Upper GI Cancer Audit (DUCA).

Key publications
  • Straatman J, van der Wielen N, Cuesta MA, Daams F, Roig Garcia J, Bonavina L, Rosman C, van Berge Henegouwen MI, Gisbertz SS, van der Peet DL, Minimally Invasive Versus Open Esophageal Resection Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial. ANN SURG 2017;266 (2):232-236 [PubMed]
  • Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch ORC, ten Kate FJW, Creemers GJM, Punt CJA, Plukker JTM, Verheul HMW, Bilgen EJS, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A, Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. LANCET ONCOL 2015;16 (9):1090-1098 [PubMed]
  • Oppedijk V, van der Gaast A, van Lanschot JJB, van Hagen P, van Os R, van Rij CM, van der Sangen MJ, Beukema JC, Rütten H, Spruit PH, Reinders JG, Richel DJ, van Berge Henegouwen MI, Hulshof MCCM, Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J CLIN ONCOL 2014;32 (5):385-391 [PubMed]
  • Biere SSAY, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JHG, Hollmann MW, de Lange ESM, Bonjer HJ, van der Peet DL, Cuesta MA, Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. LANCET 2012;379 (9829):1887-1892 [PubMed]
  • van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BPL, Richel DJ, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch ORC, ten Kate FJW, Creemers GJ, Punt CJA, Plukker JTM, Verheul HMW, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A [Contributors: Bergman JJGHM, Bartelsman JF, Bissumbar A, Blom RL, Geijsen ED, van Heijl M, Obertop H, Koning CCE, Offerhaus GJ, Omloo JM, Wilmink H , Aparicio Pages MN, van den Nieuwenhof-Biesheuvel L, Eijkenboom WMH, Koppert LB, Meijer DA, Siersema PD, Spaander MCV, Verheij C, Vollebregt C, van Krieken JHJM, van Mansum W, van Dam G, van Dullemen HM, Eerens A, van der Jagt E, Karnebeld A, Kluin P, Mul VEM, Pruim J, Siemerink E, Weersma RK, Fraikin T, Peters CWAH]] , Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. NEW ENGL J MED 2012;366 (22):2074-2084 [PubMed]
All Publications
Research programmes

Outcome Improvement in Esophago- Gastric Surgery

 Esophageal and gastric surgery is major GI surgery with high morbidity and a high postoperative recurrence rate of disease.

The research line focuses on direct postoperative care and improvenment through 1. new minimally invasive techniques, 2. better pre and postoperative care (rehabilitation), 3. evaluation of Quality of Life. Furthermore research gives insight in neo adjuvant techniques and evaluation of tumor response. 

Other focus is on improving outcome of esophageal and gastric cancer care on a national level through research with the Dutch Upper GI Cancer Audit (DUCA).

Faculty
Prof. dr. M.I. van Berge Henegouwen MD PhD

PhD Students
M.A. van Egmond
J.A.H. Gooszen
E.R.C. Hagens
E. Jezerskyte
M.C. Kalff
D. Liu
A.E. Slaman MSc
M.D. Slooter
A. Mertens MD (Universiteit Twente)
G. Pirozolo MD (Insituto Oncologica Veneto)
L. Sadeh (Clinico Oncologica Veneto)
Drs. L. van der Werf MD (Erasmus Universiteit Rotterdam)

Other research related activities
  • Membership of medical or scientific committee, Dutch Institute of Clinical Auditing (DICA), chairman scientific committee Dutch Upper GI Cancer Audit (DUCA)
  • Membership of medical or scientific committee, Werkgroep Upepr GI Chrirugie (landelijke werkgroep), Voorzitter Werkgroep Upper GI Chirurgie
  • Membership of advisory board / Consultant, Medtronic
  • Membership of advisory board / Consultant, Johnson & Johnson
Current research funding
  • Johnson & Johnson Medical BV
  • Maag, Lever, Darm Stichting
  • NIEUWE DEB CHA
  • NIEUWE DEB IND
  • Olympus Nederland B.V.
  • Stichting AMC Foundation (Vrijgesteld)